FBRX

8.50

1.43% 0.12

Handel nachbörslich: 8.86 0.36 +4.24%

Forte Biosciences Inc (FBRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.38

Offen:

$8.3

24-Stunden-Volumen:

27,014

Relative Volume:

0.58

Marktkapitalisierung:

$55.93M

Einnahmen:

Nettoeinkommen (Verlust:

$-31.48M

KGV:

-8.1731

EPS:

-1.04

Netto-Cashflow:

$-28.71M

1W Leistung:

+0.12%

1M Leistung:

+15.76%

6M Leistung:

-60.85%

1J Leistung:

-45.60%

1-Tages-Spanne:

$8.28

$8.99

1-Wochen-Bereich:

$8.25

$13.84

52-Wochen-Spanne:

$4.11

$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Firmenname

Forte Biosciences Inc

Sektor

Healthcare (1170)

Branche

Biotechnology (667)

Telefon

(310) 618-6994

Adresse

3060 PEGASUS PARK DRIVE, DALLAS, CA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

FBRX's Discussions on Twitter

Vergleichen Sie FBRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FBRX Forte Biosciences Inc	8.50	55.89M	0	-31.48M	-28.71M	-1.04
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-21	Eingeleitet	TD Cowen	Buy
2024-04-08	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2021-09-20	Hochstufung	Chardan Capital Markets	Sell → Buy
2021-09-03	Herabstufung	B. Riley Securities	Buy → Neutral
2021-09-03	Herabstufung	Chardan Capital Markets	Buy → Sell
2021-09-03	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2021-09-03	Herabstufung	Truist	Buy → Hold
2021-05-14	Eingeleitet	B. Riley Securities	Buy
2021-03-26	Eingeleitet	Citigroup	Buy
2020-08-28	Hochstufung	Chardan Capital Markets	Neutral → Buy
2020-08-25	Eingeleitet	Truist	Buy

Alle ansehen

Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten

09:24 AM

Forte Biosciences reports annual meeting results - Investing.com

09:24 AM

09:06 AM

Forte Biosciences Elects New Directors at Annual Meeting - TipRanks

09:06 AM

May 29, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

May 29, 2025

May 28, 2025

How the (FBRX) price action is used to our Advantage - news.stocktradersdaily.com

May 28, 2025

Forte Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025

Forte Biosciences Q1 Operating Expenses USD 16.124 Million - marketscreener.com

May 15, 2025

Forte Biosciences (FBRX) Advances Trials for FB102 in Celiac Disease and Vitiligo | FBRX Stock News - GuruFocus

May 15, 2025

Forte Biosciences reports Q1 EPS ($1.37), consensus (95c) - TipRanks

May 15, 2025

Forte Biosciences, Inc. Announces Results and Provides Update - Eagle-Tribune

May 15, 2025

Forte Biosciences Q1: Celiac Disease Trial Results Imminent, New Vitiligo Study Launches - Stock Titan

May 15, 2025

Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

May 15, 2025

May 10, 2025

Forte Biosciences (FBRX) Expected to Announce Earnings on Monday - Defense World

May 10, 2025

May 08, 2025

JPMorgan Chase & Co. Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 08, 2025

Royal Bank of Canada Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - Defense World

May 08, 2025

JPMorgan Chase & Co. Buys New Holdings in Innovator U.S. Equity Accelerated ETF – January (BATS:XDJA) - Defense World

May 08, 2025

(FBRX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 08, 2025

May 03, 2025

Geode Capital Management LLC Boosts Stock Position in AmpliTech Group, Inc. (NASDAQ:AMPG) - Defense World

May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025

May 01, 2025

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com

May 01, 2025

Meta Doubles Down on AI: Is the Stock Ready to Skyrocket? - The Globe and Mail

May 01, 2025

Apr 19, 2025

Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice - Healio

Apr 19, 2025

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 By Investing.com - Investing.com Canada

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 - Investing.com Australia

Apr 18, 2025

Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Apr 18, 2025

Apr 17, 2025

Mr. Ethan Billings recommends paying close attention to biotech stocks - FinancialContent

Apr 17, 2025

Apr 15, 2025

Profit from Trump’s Tariff Playbook with TipRanks’ New Comparison Tool - The Globe and Mail

Apr 15, 2025

Apr 13, 2025

Nvidia and Broadcom Helped Propel This ETF 18% Higher in a Single Day. Here's Why It's Still a Buy Now. - The Globe and Mail

Apr 13, 2025

Apr 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 07, 2025

Analysts Issue Forecasts for FBRX Q2 Earnings - Defense World

Apr 07, 2025

Equities Analysts Offer Predictions for FBRX FY2025 Earnings - Defense World

Apr 07, 2025

Apr 06, 2025

(FBRX) Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025

Apr 04, 2025

All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - MSN

Apr 04, 2025

Forte Biosciences (NASDAQ:FBRX) Given New $61.00 Price Target at Chardan Capital - The AM Reporter

Apr 04, 2025

Apr 03, 2025

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

Apr 03, 2025

Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World

Apr 03, 2025

Apr 02, 2025

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener

Apr 02, 2025

Forte Biosciences Reports 2024 Progress and Financials - TipRanks

Apr 02, 2025

Apr 01, 2025

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo

Apr 01, 2025

Mar 31, 2025

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

Mar 31, 2025

Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph

Mar 31, 2025

Mar 28, 2025

Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025

Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener

Mar 28, 2025

Forte Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025